Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

GlaxoSmithKline takes stake in Response Genetics
bizjournals
Saturday, September 15, 2012 - 11:41am
tags:
GSK, Response Genetics
Impax and J&J settle Concerta patent lawsuits
Equities.com
Saturday, September 15, 2012 - 11:39am
tags:
Impax, JNJ, Concerta, generics, patents, lawsuits
2 Factors Will Keep Abbott Laboratories Bullish
Seeking Alpha
Saturday, September 15, 2012 - 11:19am
tags:
Abbott Laboratories
5 Healthcare Stocks That Could Boost Your Portfolio By 2013
Seeking Alpha
Saturday, September 15, 2012 - 11:18am
tags:
GSK, Theravance, JNJ, Pfizer, Neuralstem
Should This News Scare Amarin Investors?
Motley Fool
Saturday, September 15, 2012 - 11:17am
tags:
Amarin
Near-Term Catalyst Could Drive ChromaDex Shares Higher
Seeking Alpha
Saturday, September 15, 2012 - 11:17am
tags:
ChromaDex, nutraceutical
Pfizer Inc (PFE): Today's Featured Drugs Laggard
The Street
Saturday, September 15, 2012 - 11:14am
tags:
Pfizer
AstraZeneca in Neutral Lane
Yahoo/Zacks
Saturday, September 15, 2012 - 11:13am
tags:
AstraZeneca
ABT Dividend Yield Pushes Past 3%
Forbes
Saturday, September 15, 2012 - 9:43am
tags:
Abbott Laboratories
Buying Into Catalyst Pharma's Fast Tracked Vigabatrim On Friday
Seeking Alpha
Saturday, September 15, 2012 - 9:43am
tags:
Catalyst Pharmaceutical Partners, Vigabatrin, CPP-109, cocaine addiction
Biotechnology News: IntraPace's New Drug Stops You From Excessive Eating
Minyanville
Saturday, September 15, 2012 - 9:39am
tags:
IntraPace, Abiliti, weight loss, obesity
Healthcare Business Review: L’Oreal’s FDA WARNING, Dara’s SWISS Deal
Wall Street Cheat Street
Saturday, September 15, 2012 - 9:37am
tags:
L’Oreal, Neuralstem, DARA Biosciences
7 Rallying Biotech Stocks Being Snapped Up By Hedge Funds
Seeking Alpha
Saturday, September 15, 2012 - 9:30am
tags:
Achillion, Affymax, Alexion, Jazz Pharmaceuticals, ONYX Pharmaceuticals, Threshold Pharmaceuticals, ViroPharma
Amgen Inc: Today's Featured Health Care Laggard
The Street
Saturday, September 15, 2012 - 9:29am
tags:
Amgen
Celgene Corporation: Today's Featured Drugs Winner
The Street
Saturday, September 15, 2012 - 9:28am
tags:
Celgene
Regeneron Pharmaceuticals Inc. (REGN): Today's Featured Health Care Winner
The Street
Saturday, September 15, 2012 - 9:27am
tags:
Regeneron
Uber-Blockbuster Potential Of Acadia's Pimavanserin: First-In-Class, Next-Generation Antipsychotic
Seeking Alpha
Saturday, September 15, 2012 - 9:26am
tags:
Acadia
Wall Street Transcript Interview with Boris Peaker of Oppenheimer & Company: Emerging-Growth Opportunities in Oncology Biotech
Yahoo/Wall St Transcript
Saturday, September 15, 2012 - 9:24am
tags:
PDL BioPharma Completes Regular Quarterly Dividend Payment
Yahoo/PR Newswire
Saturday, September 15, 2012 - 9:23am
tags:
PDL Biopharma
Biogen Idec Reaches New 52-Week High (BIIB)
The Street
Saturday, September 15, 2012 - 9:18am
tags:
Biogen

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.